Literature DB >> 16705350

[Responsibilities of the otorhinolaryngologist in the follow-up of malignancies of the head and neck].

S Tesche1, F U Metternich.   

Abstract

The aims of follow-up of head and neck cancer patients are the detection of new tumour manifestations, management of impairments after tumour therapy, psychological care and the evaluation of therapeutic efficacy. The extent, success and cost-benefit ratio of follow-up are currently under discussion. We recommend interdisciplinary cooperation between the relevant specialists, such as oncology and radiotherapy, together with the otorhinolaryngologist for reasons of cost-efficacy and improvement of long-term results. We present a follow-up schedule for patients with head and neck squamous cell carcinomas, which are the by far most common manifestation. We recommend a standardized protocol, which should be individualized depending on tumour site, size, treatment and therapeutic options in the case of tumour recurrence. The most common salivary gland malignancies are also discussed. The objective is to increase the efficacy of follow-up in patients with head and neck cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16705350     DOI: 10.1007/s00106-006-1422-7

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  19 in total

1.  [Tumor after-care: goals, results and concepts].

Authors:  I Haas
Journal:  Laryngorhinootologie       Date:  2000-11       Impact factor: 1.057

Review 2.  Prognostic factors in squamous cell carcinoma of the head and neck.

Authors:  T G Wendt; P Bank
Journal:  Onkologie       Date:  2002-06

3.  Impact of surgery on head and neck cancer patients and their caregivers.

Authors:  J Watt-Watson; J Graydon
Journal:  Nurs Clin North Am       Date:  1995-12       Impact factor: 1.208

4.  The dilemma of follow-up in head and neck cancer patients.

Authors:  I Haas; U Hauser; U Ganzer
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-05       Impact factor: 2.503

5.  Surgical treatment for pulmonary metastases of squamous cell carcinoma of the head and neck.

Authors:  K Nibu; K Nakagawa; S Kamata; K Kawabata; M Nakamizo; T Nigauri; K Hoki
Journal:  Am J Otolaryngol       Date:  1997 Nov-Dec       Impact factor: 1.808

6.  Is routine triple endoscopy cost-effective in head and neck cancer?

Authors:  A Shaha; E Hoover; J Marti; Y Krespi
Journal:  Am J Surg       Date:  1988-06       Impact factor: 2.565

7.  Lung cancer in patients with head and neck cancer. Incidence and long-term survival.

Authors:  U Atabek; M A Mohit-Tabatabai; S Raina; B F Rush; K S Dasmahapatra
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

8.  Coping with cancer.

Authors:  G M Manuel; S Roth; F J Keefe; B A Brantley
Journal:  J Human Stress       Date:  1987

9.  [Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx].

Authors:  M Wolfensberger
Journal:  HNO       Date:  1988-01       Impact factor: 1.284

10.  Psychological distress in head and neck cancer patients 7-11 years after curative treatment.

Authors:  K Bjordal; S Kaasa
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  3 in total

1.  [Incidence, latency, and prognosis of local and regional recurrences in patients with upper aerodigestive tract cancer treated by laser microsurgery: influence of initial tumor parameters].

Authors:  M C Jäckel; A Martin; W Steiner
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

2.  [Patients with malignancies of the oro- and hypopharynx as well as the larynx. Significance/importance of oncological aftercare consultation].

Authors:  K Fritzsche; K Breitenstein; D Esser
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

3.  [Follow up in head and neck cancer].

Authors:  Csilla Neuchrist; Michael Formanek
Journal:  Wien Med Wochenschr       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.